Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
06.05.FDA approves Selarsdi injection as interchangeable with Stelara
05.05.Chinese regulator grants priority review for InnoCare's solid tumour treatment
05.05.FDA accepts Novo Nordisk's NDA submission for weight management therapy
02.05.Q1 earnings pulse check: companies tentative on pharma-specific tariffs
02.05.MHRA authorises Bavarian Nordic's chikungunya virus vaccine
02.05.Entering the era of prenatal gene therapies
02.05.HHS launches $500m universal vaccines initiative
02.05.FDA awards RMAT status to 4DMT diabetic macular oedema therapy
02.05.PTSD market expected to reach $5.5bn across the 7MM by 2034
02.05.Repare signs out-licensing deal with DCx Biotherapeutics
01.05.Biogen's Q1 revenue soars past estimates as rare disease pivot pays off
01.05.Lilly's Q1 2025 revenue jumps 45%, but CVS shift boosts Novo's Wegovy
01.05.New £1bn cancer research hub planned for South London
01.05.Dimerix and Amicus to commercialise DMX-200 in US
01.05.End-to-end solutions: why every link in the pharmaceutical supply chain counts
01.05.GSK remains resilient on tariffs as Q1 sales rise 4%
01.05.Novartis to strengthen renal disease portfolio with Regulus
01.05.FDA approves J&J's Imaavy for generalised myasthenia gravis
01.05.Investors insist halted biotech IPOs will return in 2025
30.04.Biopharma venture financing declines 20.2% YOY in Q1 2025 amid persistent investor caution
30.04.Boehringer, Oxford University and Cumulus to explore brain activity in BPD
30.04.Trump's first 100 days tout US-bound pharma investments amid tariff worries
30.04.Donald Trump's first 100 days: Impact on the healthcare industry
30.04.Magazine: The GLP-1 shortage is over. What's next for compounders?
30.04.FDA approves AbbVie's upadacitinib for giant cell arteritis